|Bid||18.34 x 1100|
|Ask||18.30 x 800|
|Day's Range||18.10 - 18.85|
|52 Week Range||16.68 - 38.78|
|Beta (3Y Monthly)||1.88|
|PE Ratio (TTM)||30.57|
|Earnings Date||Jul 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||33.00|
WINTER SPRINGS, Fla., July 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
The big shareholder groups in IRadimed Corporation (NASDAQ:IRMD) have power over the company. Institutions often own...
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Attractive stocks have exceptional fundamentals. In the case of IRadimed Corporation (NASDAQ...
On a per-share basis, the Winter Springs, Florida-based company said it had net income of 15 cents. Earnings, adjusted for pretax gains, came to 13 cents per share. The maker of IV devices that can be ...
Reports first quarter 2019 revenue of $8.4 millionReports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019.
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WINTER SPRINGS, Fla., April 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the.
Roger Susi became the CEO of IRadimed Corporation (NASDAQ:IRMD) in 2004. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll look at a snap shot...
IRADIMED CORPORATION (IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2”) monitoring features of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient vital signs monitoring system. “This 510(k) clearance allows for neonatal use of the SpO2 and CO2 features of the 3880 MRI-compatible patient vital signs monitor. With this clearance, the full capabilities of the 3880 MRI-compatible patient vital signs monitoring system are now available for use on all patients.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do bet...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share pricesRead More...
iRadimed Corp (NASDAQ:IRMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Anyone researching IRadimed Corporation (NASDAQ:IRMD) might want to consider theRead More...
There is an old story about Hubert Lyautey, a French army marshal, elder statesman and a former administrator of the French colony of Morocco. In the story, Lyautey goes to his gardener one day and asks him to plant a certain type of tree in the back garden of his chateau. "In that case," Lyautey replied, "there is no time to lose.
iRadimed (IRMD) delivered earnings and revenue surprises of 23.08% and 1.82%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Winter Springs, Florida-based company said it had net income of 14 cents. Earnings, adjusted for stock option expense, were 16 cents per share. The maker of IV devices that can ...
Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first.